Chylous ascites due to signet ring cell gastric adenocarcinoma

Nigerian Journal of Clinical Practice

Volumn 15, Issue 4, 2012, Pages 487-490

  De Mello, R A ^a,b   Gregorio T ^b   Cardoso, T ^b  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b University of Porto   (Portugal)

Author keywords

Carcinoma; Chylous ascites; Paracentesis; Signet ring cell; Stomach neoplasm

Indexed keywords

ARTICLE; CASE REPORT; CHYLOUS ASCITES; HUMAN; MALE; MIDDLE AGED; SIGNET RING CARCINOMA; STOMACH TUMOR;

CARCINOMA, SIGNET RING CELL; CHYLOUS ASCITES; HUMANS; MALE; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 84871646628     PISSN: 11193077     EISSN: None     Source Type: Journal    
DOI: 10.4103/1119-3077.104536     Document Type: Article

References (15)

1. Smith EK, Ek E, Croagh D, Spain LA, Farrell S. Acute chylous ascites mimicking acute appendicitis in a patient with pancreatitis. World J Gastroenterol 2009;15:4849-52.
2. Cárdenas A, Chopra S. Chylous ascites. Am J Gastroenterol 2002;97:1896-900.
3. Huang Q, Jiang Z, Jiang J, Li N, Li J. Chylous ascites: Treated with total parenteral nutrition and somatostatin. World J Gastroenterol 2004;10:2588-91. (Pubitemid 39206787)
4. Saif M, Siddiqui I, Sohail M. Management of ascites due to gastrointestinal malignancy. Ann Saudi Med 2009;29:369-77.
5. Saif MW. Malignant Ascites Associated with Carcinoma of the Prostate. J Appl Res 2005;5:305-11. (Pubitemid 40962176)
6. Maehara Y, Sakaguchi Y, Moriguchi S, Orita H, Korenaga D, Kohnoe S, et al. Signet ring cell carcinoma of the stomach. Cancer 1992;69:1645-50.
7. Zhang M, Zhu G, Zhang H, Gao H, Xue Y. Clinicopathologic Features of Gastric Carcinoma with Signet Ring Cell Histology. J Gastrointest Surg 2010;14:601-6.
8. Griniatsos J, Dimitriou N, Kyriaki D, Velidaki A, Sougioultzis S, Pappas P. Chylorrhea complicating D2+a gastrectomy: Review of the literature and clarification of terminology apropos one case. Chin Med J (Engl) 2010;123:2279-83.
9. Qi J, Gu Z, Chen F, Zhang L, Chen J. Management of postoperative chyloretroperitoneum in adults. Singapore Med J 2009;50:e338-41.
10. Ajani JA, Rodriguez W, Bodoky G, Moiseyenko V, Lichinitser M, Gorbunova V, et al. Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: The FLAGS trial. J Clin Oncol. 2010;28:1547-53.
11. Tokar M, Bobilev D, Ariad S, Geffen D. Disseminated intravascular coagulation at presentation of advanced gastric cancer. Isr Med Assoc J 2006;8:853-5. (Pubitemid 46017769)
12. Dos Santos VM, Rodrigues DB, Castro EC, Saldanha JC, Soares S, Teixeira VP, et al. Widespread hematogenous metastases and Trousseau's syndrome in gastric adenocarcinoma. Rev Hosp Clin Fac Med Sao Paulo 2001;56:91-6.
13. Chao Y, Teng HC, Hung HC, King KL, Li CP, Chi KH, et al. Successful initial treatment with weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin chemotherapy in advanced gastric cancer patients with disseminated intravascular coagulation. Jpn J Clin Oncol 2000;30:122-5. (Pubitemid 30335835)
14. Takai H, Kondoh E, Sato Y, Kakui K, Tatsumi K, Konishi I. Disseminated intravascular coagulation as the presenting sign of gastric cancer during pregnancy. J Obstet Gynaecol Res. 2011;37:1717-9.
15. Rhee J, Han S, Oh D, Im S, Kim T, Bang Y. Clinicopathologic features and clinical outcomes of gastric cancer that initially presents with disseminated intravascular coagulation: A retrospective study. J Gastroenterol Hepatol 2010;25:1537-42.